Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 675 of 1361 entries
View as:

Nausea in Patients Receiving Hydromorphone vs Oxycodone After Total Hip Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02295124 Org: User:
Start: 08/31/12 End: 01/31/16 Due: 01/31/17

Fitness Training Using WBEMS Among Individuals With SCI

Phase: N/A Priority: Normal
NCT ID: NCT04307017 Org: User:
Start: 02/01/20 End: 12/31/20 Due: 12/31/21

Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone

Phase: N/A Priority: Normal
NCT ID: NCT00609934 Org: User:
Start: 12/31/07 End: 10/31/14 Due: 10/31/15

Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity

Phase: N/A Priority: Normal
NCT ID: NCT04439045 Org: User:
Start: 06/24/20 End: 09/09/21 Due: 09/09/22

Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy

Phase: N/A Priority: Normal
NCT ID: NCT00402805 Org: User:
Start: 10/31/06 End: 07/31/07 Due: 07/31/08

PRG With and Without Gastropexy

Phase: N/A Priority: Normal
NCT ID: NCT04107974 Org: User:
Start: 04/01/19 End: 11/11/19 Due: 11/11/20

Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT00145964 Org: User:
Start: 08/31/04 End: - Due: -

Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00329277 Org: User:
Start: 04/30/06 End: 01/31/08 Due: 01/31/09

Durvalumab and Oleclumab in Resectable PDAC

Phase: N/A Priority: Normal
NCT ID: NCT06060405 Org: User:
Start: 11/29/23 End: 10/30/26 Due: 10/30/27

PSMA PET Registry (18F-DCFPyL)

Phase: N/A Priority: Normal
NCT ID: NCT03535831 Org: User:
Start: 04/27/18 End: 12/31/25 Due: 12/31/26

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04804371 Org: User:
Start: 03/04/21 End: 02/22/26 Due: 02/22/27

Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT04219137 Org: User:
Start: 11/14/19 End: 11/30/27 Due: 11/30/28

Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04092179 Org: User:
Start: 11/05/20 End: 10/26/23 Due: 10/26/24

Improving the Assessment of SLE Disease Activity

Phase: N/A Priority: Normal
NCT ID: NCT03144063 Org: User:
Start: 07/11/17 End: 06/04/20 Due: 06/04/21

Feasibility Study of the Advanced Symptom Management System (ASyMS) in Canadian Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03335189 Org: User:
Start: 11/15/17 End: 05/28/19 Due: 05/28/20

Comparison of OpeN VErsus RoboTic Partial Nephrectomy

Phase: N/A Priority: Normal
NCT ID: NCT04011891 Org: User:
Start: 11/01/19 End: 07/24/23 Due: 07/24/24

Preventing Delayed Graft Function in Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT06724211 Org: User:
Start: 01/15/25 End: 04/30/26 Due: 04/30/27

Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT06704243 Org: User:
Start: 05/24/24 End: 06/30/25 Due: 06/30/26

Nurse-performed Lung Ultrasound Versus Chest Radiography for Detection of Pneumothorax.

Phase: N/A Priority: Normal
NCT ID: NCT04678726 Org: User:
Start: 07/31/23 End: 12/31/25 Due: 12/31/26

Cardiac Rehabilitation Peer Mentorship

Phase: N/A Priority: Normal
NCT ID: NCT02204449 Org: User:
Start: 07/31/14 End: 01/31/15 Due: 01/31/16

Evaluation of a Supportive Housing Program for Adults Who Are Unhoused and Have Complex Health Needs

Phase: N/A Priority: Normal
NCT ID: NCT06723093 Org: User:
Start: 11/06/24 End: 05/01/27 Due: 05/01/28

MRI Guided Focal Laser Ablation of Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03650595 Org: User:
Start: 03/29/18 End: 06/30/28 Due: 06/30/29

Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)

Phase: N/A Priority: Normal
NCT ID: NCT00188318 Org: User:
Start: 06/30/98 End: 05/31/10 Due: 05/31/11

Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01222143 Org: User:
Start: 10/31/10 End: 04/30/15 Due: 04/30/16

TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04967430 Org: User:
Start: 08/27/21 End: 06/30/22 Due: 06/30/23